Your browser doesn't support javascript.
loading
Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.
Munakata, Wataru; Ando, Kiyoshi; Hatake, Kiyohiko; Fukuhara, Noriko; Kinoshita, Tomohiro; Fukuhara, Suguru; Shirasugi, Yukari; Yokoyama, Masahiro; Ichikawa, Satoshi; Ohmachi, Ken; Gion, Naokazu; Aoi, Arata; Tobinai, Kensei.
Affiliation
  • Munakata W; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Ando K; Department of Hematology and Oncology, Tokai University, Isehara, Japan.
  • Hatake K; Department of Hematology and Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Fukuhara N; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kinoshita T; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Fukuhara S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Shirasugi Y; Department of Hematology and Oncology, Tokai University, Isehara, Japan.
  • Yokoyama M; Department of Hematology and Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ichikawa S; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Ohmachi K; Department of Hematology and Oncology, Tokai University, Isehara, Japan.
  • Gion N; Department of Statistical Analysis, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
  • Aoi A; Department of Oncology Clinical Development Planning, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
  • Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Cancer Sci ; 110(5): 1686-1694, 2019 May.
Article in En | MEDLINE | ID: mdl-30815927

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Leukemia, Lymphocytic, Chronic, B-Cell / Protein Kinase Inhibitors / Imidazoles / Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Sci Year: 2019 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Leukemia, Lymphocytic, Chronic, B-Cell / Protein Kinase Inhibitors / Imidazoles / Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Sci Year: 2019 Type: Article Affiliation country: Japan